Keywords
Screening Programs
Public Health
Health Disparities
Amazonas
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze the epidemiological profile of populations with altered cytology and access to colposcopy in Amazonas, correlating health indicators with geographical and socioeconomic factors. Methods: An epidemiological, ecological, and retrospective study (2020–2025) was conducted using SISCAN and DATASUS data. Variables such as age group, MHDI, and distance from the capital were analyzed. Chi-Square, Kruskal-Wallis, Spearman correlation, and K-means clustering tests were applied using R software (v. 4.5.0). Results: A positive association was observed between the capital and age groups over 50, while the interior showed greater representation among those aged 30 to 40. Distance from Manaus correlated negatively with cytological coverage and the prevalence of normal exams, resulting in higher proportional demand for colposcopy in remote areas. MHDI and cytological coverage showed a positive correlation with the prevalence of normal results. Conclusion: Geographical barriers and socioeconomic disparities in Amazonas compromise patient follow-up. Cervical cancer control in the region requires strengthening public policies that address logistical challenges and promote equity, with diagnostic decentralization and the expansion of vaccine coverage and qualified screening being essential.
References
ARAÚJO ES, et al. Avaliação do seguimento de mulheres com exames citopatológicos alterados de acordo com as condutas preconizadas pelo Ministério da Saúde em Goiânia, Goiás. Revista Brasileira de Cancerologia, 2014; 60(1): 7-13.
BRASIL. Ministério da Saúde. Instituto Nacional de Câncer (INCA). Controle do câncer do colo do útero. 2. ed. Rio de Janeiro: INCA, 2016.
BRASIL. Ministério da Saúde. Portaria MS nº 4, de 6 de janeiro de 2025. Diretrizes brasileiras para o rastreamento do câncer do colo do útero. Diário Oficial da União: seção 1, Brasília, DF, p. XX, 7 jan. 2025.
CALENDÁRIO de vacinação recomendado para crianças e adolescentes com 18 anos ou menos, Estados Unidos, 2025. Centros de Controle e Prevenção de Doenças. Revisado em: 7 ago. 2025.
CARVALHO PG, et al. Trajetórias assistenciais de mulheres entre diagnóstico e início de tratamento do câncer do colo uterino. Saúde em Debate, 2018; 42(118): 687-701.
CAVALCANTE GHO, REIS GJ. Avaliação do seguimento de lesões precursoras de câncer do colo do útero – uma revisão bibliográfica. Pesquisa e Ensino em Ciências Exatas e da Natureza, 2021; 5: e1741.
CHARRAD M, et al. NbClust: An R Package for Determining the Relevant Number of Clusters in a Data Set. Journal of Statistical Software, 2014; 61(6): 1-36.
DALMOLIN SP, et al. Mulheres com exames citopatológicos alterados: avaliação do seguimento de acordo com as condutas preconizadas pelo Ministério da Saúde. Revista Brasileira de Análises Clínicas, 2016; 48(3): 235-239.
HARTIGAN JA, WONG MA. Algorithm AS 136: A K-means clustering algorithm. Applied Statistics, 1979; 28: 100–108.
HERNÁNDEZ-SILVA CD, et al. HPV and Cervical Cancer: Molecular and Immunological Aspects, Epidemiology and Effect of Vaccination in Latin American Women. Viruses, 2024; 16(2): e327.
HOLLANDER M, WOLFE DA. Nonparametric Statistical Methods. New York: John Wiley & Sons, 1973.
KARIMI P, et al. Exploring the Intricacies of Cervical Intraepithelial Neoplasia and Its Connection with HPV: A Narrative Review. Iranian Journal of Public Health, 2024; 53(12): 2636-2646.
LIU B, AI H. Comprehensive insights into human papillomavirus and cervical cancer: Pathophysiology, screening, and vaccination strategies. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2024; 1879(6): e189110.
MERCK SHARP & DOHME FARMACÊUTICA LTDA. GARDASIL® 9: vacina papilomavírus humano 9-valente (recombinante). São Paulo: Merck Sharp & Dohme, 2022. Bula de remédio.
MINISTÉRIO DA SAÚDE (Brasil). Secretaria de Vigilância em Saúde e Ambiente. Instrução Normativa do Calendário Nacional de Vacinação 2025. Brasília, DF: Ministério da Saúde, 19 nov. 2025.
NEMENYI P. Distribution-free Multiple Comparisons. 1963. Thesis (Ph.D. in Statistics) – Princeton University, Princeton, 1963.
OLIVEIRA AK, et al. Infecção pelo HPV - Rastreamento, diagnóstico e conduta nas lesões HPV induzidas. FEMINA, 2021; 49(3): 166-172.
PRILEPSKAYA VN, IUROVA MV. Current approaches in the diagnosis, treatment and prevention of HPV-associated cervical diseases: practical recommendations. A review. Gynecology, 2023; 25(1): 4-11.
REVISTA BRASILEIRA DE PATOLÓGIA DO TRATO GENITAL INFERIOR E COLPOSCOPIA. Estratégias para acelerar a eliminação do câncer do colo útero. Revista Brasileira de Patologia do Trato Genital Inferior, 2024; 8: 1.
SILVA CS, GUIMARÃES AO. Panorama epidemiológico das internações por neoplasia maligna de colo uterino no Brasil: um estudo retrospectivo. Brazilian Journal of Implantology and Health Sciences, 2025; 7(6): 342-3
TEWARI KS. Cervical Cancer. The New England Journal of Medicine, 2025; 392(10): 936-946.
WORLD HEALTH ORGANIZATION. Global strategy to accelerate the elimination of cervical cancer as a public health problem. Geneva: WHO, 2020.
ZANINE RM. Doenças do trato genital inferior e colposcopia. Rio de Janeiro: Thieme Revinter, 2020.